A novel, non-hallucinogenic, experimental drug shows statistically significant, rapid, and durable improvement in PTSD symptom severity in a phase 2 trial.
In the DSM-5 released in May, PTSD just got more complex. It added a new symptom domain of "negative alterations in cognitions or mood," and expanded the hyperarousal domain to include aggressive, ...
Quitting cannabis may yield greater improvements in PTSD symptoms than continued use in adults with both PTSD and cannabis ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results